Search results for "specificity"

showing 10 items of 2234 documents

Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues.

2003

Abstract Mannose-binding lectin (MBL), a member of the collectin family, binds to carbohydrate structures on the surfaces of micro-organisms and may serve as a recognition molecule of the lectin pathway of complement activation. In rodents two forms, MBL-A and MBL-C, were described and shown to be products of two related, but uncoupled, genes. The liver is the main source of MBL biosynthesis. For rat MBL-A, expression has also been described in the kidney. Here we report that the two forms of murine MBL are differentially expressed in a number of nonhepatic tissues. Real-time RT-PCR revealed that the liver is the major site of expression for both MBL genes. Lower copy numbers were found in …

MaleLymphoid TissueImmunologyCollectinchemical and pharmacologic phenomenaIn situ hybridizationMannose-Binding LectinMiceIntestine SmallImmunology and AllergyAnimalsProtein IsoformsIn Situ HybridizationMannan-binding lectinMice Inbred BALB CInnate immune systembiologyLectinbacterial infections and mycosesAcquired immune systemMolecular biologyImmunohistochemistryComplement systemAnimals NewbornLiverOrgan SpecificityLectin pathwaybiology.proteinFemaleSpleenJournal of immunology (Baltimore, Md. : 1950)
researchProduct

l-[3H]lysine binding to rat retinal membrane: I. Quantitative determination and characterization of the binding sites

1986

A saturable reversible binding to membranes from rat retina has been found for L-[3H]lysine. Specific binding is time, temperature and protein concentration-dependent, and shows stereospecificity. The best computer fits of the experimental data are obtained with a receptor model based on two independent binding sites, of which only one site with a Kd value of 229.4 +/- 14.23 nM and a Bmax of 2.04 +/- 0.11 pmol/mg protein could be characterized satisfactorily. Several compounds included putative neurotransmitters have moderate or no affinity for L-lysine binding sites. A different pattern of distribution of L-[3H]lysine binding sites is observed among various regions of the brain, with the h…

MaleLysineBiologyBiochemistryRetinaCellular and Molecular Neurosciencechemistry.chemical_compoundStereospecificitymedicineAnimalsVisual PathwaysBinding siteReceptorRetinaBinding SitesLysineTemperatureBrainRats Inbred StrainsRetinalGeneral MedicineRatsCortex (botany)KineticsMembranemedicine.anatomical_structureBiochemistrychemistryRegression AnalysisNeurochemical Research
researchProduct

Genes involved in sex pheromone discrimination in Drosophila melanogaster and their background-dependent effect.

2012

International audience; Mate choice is based on the comparison of the sensory quality of potential mating partners, and sex pheromones play an important role in this process. In Drosophila melanogaster, contact pheromones differ between male and female in their content and in their effects on male courtship, both inhibitory and stimulatory. To investigate the genetic basis of sex pheromone discrimination, we experimentally selected males showing either a higher or lower ability to discriminate sex pheromones over 20 generations. This experimental selection was carried out in parallel on two different genetic backgrounds: wild-type and desat1 mutant, in which parental males showed high and l…

MaleMESH: Olfactory Perception[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionMESH : Animals Genetically Modifiedlcsh:MedicineGenes InsectMESH: Genes InsectBreedingMESH : Behavior AnimalMESH: ReproductionCourtshipAnimals Genetically ModifiedSexual Behavior Animal0302 clinical medicineMESH : Drosophila melanogasterMESH: Behavior AnimalMESH : FemaleMESH: AnimalsMatingSex AttractantsMESH: Sexual Behavior Animal10. No inequalitylcsh:Sciencemedia_commonGenetics0303 health sciencesMultidisciplinaryEcologyBehavior AnimalReproductionMESH : Genes InsectAnimal ModelsMESH : ReproductionSensory SystemsDrosophila melanogasterMESH: Sex AttractantsMate choiceSex pheromoneAlimentation et NutritionFemaleDrosophila melanogasterMESH : MutationResearch ArticleMESH: Mutationmedia_common.quotation_subjectMESH : BreedingMESH : MaleMESH: CourtshipContext (language use)MESH: BreedingBiologyMESH: Drosophila melanogasterMESH: Animals Genetically Modified03 medical and health sciencesModel OrganismsSpecies SpecificityMESH : Olfactory PerceptionGeneticsFood and NutritionAnimalsMESH : Species SpecificityMESH: Species SpecificityAlleleMESH : Sexual Behavior AnimalBiology030304 developmental biologyEvolutionary BiologyMESH : Sex AttractantsAnimals;Animals;Genetically Modified;Behavior;Animal;Breeding;Courtship;Drosophila melanogaster;Female;Genes;Insect;Male;Mutation;Olfactory Perception;Reproduction;Sex Attractants;Sexual Behavior;Species SpecificityMESH : Courtshiplcsh:RCourtshipbiology.organism_classificationOlfactory PerceptionMESH: MaleMutationSex Attractantslcsh:QMESH : AnimalsMESH: Female[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Sensitivity to change of two depression rating scales for stroke patients.

2010

Objective: To assess the sensitivity to change of two depression scales for stroke patients: the Aphasic Depression Rating Scale (ADRS), which is a 9-item external assessment, and the Visual Analog Mood Scale (VAMS), which is a visual self-assessment scale. Patients: Forty-nine stroke patients admitted to two rehabilitation units. Methods: Symptoms of depression were assessed twice at a one-month interval (D0—D30) using the ADRS, the VAMS, and by a trained psychologist (PSY). Sensitivity to change was assessed by effect size and standardized response mean. A one-way ANOVA on ranks was performed to determine if the scales distinguished between deteriorated, stable and improved patient statu…

MaleMESH: Psychiatric Status Rating ScalesMESH : StrokeStroke patientmedicine.medical_treatmentMESH: Depressive DisorderMESH : AgedMESH : Analysis of VarianceSeverity of Illness IndexMood scale[ SDV.NEU.SC ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive Sciences0302 clinical medicineMESH : Female030212 general & internal medicineDepression (differential diagnoses)MESH: AgedMESH : AphasiaRehabilitationMESH: Middle AgedRehabilitationStroke Rehabilitation[SDV.NEU.SC]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Cognitive SciencesMiddle AgedMESH : AdultStrokeFemaleMESH : Severity of Illness IndexPatient statusMESH : Sensitivity and SpecificityMESH : Psychiatric Status Rating ScalesPsychologyClinical psychologyAdultmedicine.medical_specialtyMESH : MalePhysical Therapy Sports Therapy and RehabilitationSensitivity and SpecificityMESH: Stroke03 medical and health sciencesRating scaleMESH: Severity of Illness IndexMESH: Analysis of VarianceAphasiamedicineHumansMESH : Middle AgedSensitivity to changeAgedMESH: AphasiaPsychiatric Status Rating ScalesAnalysis of VarianceDepressive DisorderMESH: HumansMESH : HumansMESH: AdultMESH: Sensitivity and SpecificityMESH: MaleMESH : Depressive DisorderPhysical therapyMESH: Female030217 neurology & neurosurgery
researchProduct

Liver methylene fraction by dual- and triple-echo gradient-echo imaging at 3.0T: Correlation with proton MR spectroscopy and estimation of robustness…

2011

Purpose To assess the systematic errors in liver methylene fraction (LMF) resulting from fat–fat interference effects with dual- and triple-echo gradient-recalled-echo Dual/Triple GRE) sequences and to test the robustness of these sequences after iron overloading. Materials and Methods Forty type-2 diabetic patients underwent LMF measurement by 3.0T 1H magnetic resonance spectroscopy (corrected for T1 and T2 decays) as the reference standard and liver fat fraction (%Fat) measurement by four Dual/Triple GRE sequences with 20° and 60° flip angle (α), corrected for T1 recovery. The same four sequences were repeated in eight patients after ferumoxide injection. Corrections for systematic errors…

MaleMagnetic Resonance SpectroscopyMESH : Fatty LiverMESH: Echo-Planar Imaging[SDV]Life Sciences [q-bio]Carbon Compounds InorganicMESH : Statistics as TopicStatistics as TopicMESH : AgedContrast MediaMESH : Carbon Compounds InorganicMESH : Tissue Distribution030218 nuclear medicine & medical imagingCorrelationchemistry.chemical_compound0302 clinical medicineMESH : DextransNon-alcoholic Fatty Liver DiseaseMESH : FemaleTissue DistributionMESH: DextransMethyleneMagnetite NanoparticlesMESH: Fatty LiverMESH: AgedMESH: Middle Agedmedicine.diagnostic_testEcho-Planar ImagingDextransNuclear magnetic resonance spectroscopyMESH : AdultMiddle AgedMESH: Reproducibility of ResultsAdipose TissueLiverFemale030211 gastroenterology & hepatologyMESH : Sensitivity and SpecificityProtonsMESH: Adipose TissueAdultIron OverloadMESH : MaleMESH: Magnetite NanoparticlesMESH : Adipose TissueSensitivity and SpecificityMESH: Iron Overload03 medical and health sciencesFlip angleRobustness (computer science)MESH: Contrast MediaLinear regressionmedicineMESH : ProtonsHumansMESH : Middle AgedRadiology Nuclear Medicine and imagingMESH: Tissue DistributionMESH: Statistics as TopicAgedMESH : Contrast MediaMESH : Iron OverloadMESH: HumansMESH : Echo-Planar Imaging[ SDV ] Life Sciences [q-bio]MESH: Magnetic Resonance Spectroscopybusiness.industryMESH : Reproducibility of ResultsMESH : HumansMESH: Biological MarkersMESH: Carbon Compounds InorganicMESH : LiverMESH : Magnetite NanoparticlesReproducibility of ResultsMESH: AdultMagnetic resonance imagingMESH: MaleMESH: Sensitivity and SpecificityProton mr spectroscopyMESH : Biological MarkersFatty LiverchemistryMESH : Magnetic Resonance SpectroscopyMESH: ProtonsNuclear medicinebusinessMESH: FemaleBiomarkersMESH: LiverJournal of Magnetic Resonance Imaging
researchProduct

1-imidazolyl(alkyl)-substituted di- and tetrahydroquinolines and analogues: syntheses and evaluation of dual inhibitors of thromboxane A(2) synthase …

2000

A series of 1-imidazolyl(alkyl)-substituted quinoline, isoquinoline, naphthalene, benzo[b]furan, and benzo[b]thiophene derivatives was synthesized as dual inhibitors of thromboxane A(2) synthase (P450 TxA(2)) and aromatase (P450 arom). Dual inhibition of these enzymes could be a novel strategy for the treatment of mammary tumors and the prophylaxis of metastases. The most potent dual inhibitors, 5-(2-imidazol-1-ylethyl)-7,8-dihydroquinoline (31) (P450 TxA(2): IC(50) = 0.29 microM; P450 arom: IC(50) = 0.50 microM) and its 5, 6-saturated analogue 30 (P450 TxA(2): IC(50) = 0.68 microM; P450 arom: IC(50) = 0.38 microM), showed a stronger inhibition of both target enzymes than the reference comp…

MaleMagnetic Resonance SpectroscopyThromboxaneStereochemistryIn Vitro TechniquesSubstrate SpecificityRats Sprague-DawleyThromboxane A2chemistry.chemical_compoundLipoxygenaseThromboxane A2MicrosomesDrug DiscoveryAnimalsHumansDazoxibenIsoquinolineEnzyme InhibitorsbiologyAromatase InhibitorsImidazolesRatsThromboxane B2Thromboxane B2chemistrybiology.proteinQuinolinesMolecular MedicineSpectrophotometry UltravioletThromboxane-A synthaseCyclooxygenaseThromboxane-A SynthaseJournal of medicinal chemistry
researchProduct

High-frequency conductive hearing loss as a diagnostic test for incomplete ossicular discontinuity in non-cholesteatomatous chronic suppurative otiti…

2017

Chronic suppurative otitis media, with or without cholesteatoma, may lead to erosion of the ossicles and discontinuity of the ossicular chain. In incomplete ossicular discontinuity (IOD), partial erosion of the ossicles occurs, but some sound transmission is noted throughout the ossicular chain. High-frequency conductive hearing loss (HfCHL) has been considered a hallmark of incomplete ossicular discontinuity. This study aims to evaluate the use of HfCHL as a preoperative predictor of IOD in patients with non-cholesteatomatous chronic suppurative otitis media. The HfCHL test was defined as the preoperative air-bone gap (ABG) at 4 kHz minus the average of the ABG at 0.25 and 0.5 kHz. The tes…

MaleMedical DoctorsHealth Care ProvidersChronic Suppurative Otitis MediaHearing Loss Conductivelcsh:MedicineOtologyDeafnessOtitis Media Suppurative0302 clinical medicineMedicine and Health SciencesMedical PersonnelProspective Studieslcsh:Science030223 otorhinolaryngologyHearing DisordersEar OssiclesMultidisciplinarymedicine.diagnostic_testCholesteatomaAudiologyMiddle AgedConductive hearing lossProfessionsmedicine.anatomical_structureMiddle earAudiometry Pure-ToneFemaleRadiologymedicine.symptomAnatomyResearch ArticleAdultmedicine.medical_specialtySoft TissuesAdolescentHearing lossSurgical and Invasive Medical ProceduresSensitivity and Specificity03 medical and health sciencesYoung AdultDiagnostic MedicinePhysiciansmedicineotorhinolaryngologic diseasesHumansSurgeonsOssiclesbusiness.industrylcsh:RMiddle EarBiology and Life SciencesGold standard (test)medicine.diseaseHealth CareOtitis MediaBiological TissueOtorhinolaryngologyEarsPeople and Placeslcsh:QPopulation Groupingssense organsAudiometrybusinessHead030217 neurology & neurosurgeryPLoS ONE
researchProduct

A smart tele-cytology point-of-care platform for oral cancer screening.

2019

Early detection of oral cancer necessitates a minimally invasive, tissue-specific diagnostic tool that facilitates screening/surveillance. Brush biopsy, though minimally invasive, demands skilled cyto-pathologist expertise. In this study, we explored the clinical utility/efficacy of a tele-cytology system in combination with Artificial Neural Network (ANN) based risk-stratification model for early detection of oral potentially malignant (OPML)/malignant lesion. A portable, automated tablet-based tele-cytology platform capable of digitization of cytology slides was evaluated for its efficacy in the detection of OPML/malignant lesions (n = 82) in comparison with conventional cytology and hist…

MaleMedical DoctorsHealth Care ProvidersPathology and Laboratory Medicine030218 nuclear medicine & medical imaging0302 clinical medicineCohen's kappaConventional cytologyCytologyImage Processing Computer-AssistedMedicine and Health SciencesMedical PersonnelEarly Detection of CancerMultidisciplinaryOral cancer screeningQRMiddle AgedTelemedicine3. Good healthProfessionsOncology030220 oncology & carcinogenesisMedicineFemaleMouth NeoplasmsRadiologyAnatomyRisk assessmentAlgorithmsResearch ArticleComputer and Information SciencesDysplasiamedicine.medical_specialtyHistologyCytodiagnosisPoint-of-Care SystemsRemote diagnosisScienceEarly detectionRisk AssessmentSensitivity and Specificity03 medical and health sciencesSigns and SymptomsDiagnostic MedicineArtificial IntelligenceCancer Detection and DiagnosismedicineHumansArtificial Neural NetworksPoint of careComputational Neurosciencebusiness.industryBiology and Life SciencesComputational BiologyCell BiologyPathologistsHealth CarePeople and PlacesLesionsPopulation GroupingsNeural Networks ComputerCytologybusinessNeurosciencePLoS ONE
researchProduct

Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human

2004

Abstract 4-Bromo-2,5-dimethoxyphenethylamine (2C-B) is a psychoactive designer drug of abuse that is sold under the street names “Venus”, “Bromo”, “Erox”, “XTC” or “Nexus”. Concern has been raised because only little is known about its toxicity and metabolism in humans. In the present study we incubated 2C-B with human, monkey, dog, rabbit, rat and mouse hepatocytes to identify the metabolites formed and to determine possible toxic effects as evidenced by an ATP assay. Our data allow construction of the main metabolic pathways of 2C-B. Oxidative deamination results in the 2-(4-bromo-2,5-dimethoxyphenyl)-ethanol (BDMPE) and 4-bromo-2,5-dimethoxyphenylacetic acid (BDMPAA) metabolites. Additio…

MaleMetaboliteDeaminationMice Inbred StrainsBiologyToxicologyGas Chromatography-Mass SpectrometryRats Sprague-DawleyMicechemistry.chemical_compoundAdenosine TriphosphateDogsSpecies SpecificitymedicineAnimalsHumansCells CulturedDemethylationDose-Response Relationship DrugMolecular Structure25-Dimethoxy-4-MethylamphetamineIllicit DrugsOxidative deaminationMetabolismMiddle AgedRatsMacaca fascicularisMetabolic pathwaymedicine.anatomical_structurechemistryBiochemistryDeaminationHepatocyteHepatocytesRabbitsOxidation-ReductionDrug metabolismToxicology
researchProduct

Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays

2013

LCAT (lecithin:cholesterol acyltransferase) catalyzes the transacylation of a fatty acid of lecithin to cholesterol, generating a cholesteryl ester and lysolecithin. The knowledge of LCAT atomic structure and the identification of the amino acids relevant in controlling its structure and function are expected to be very helpful to understand the enzyme catalytic mechanism, as involved in HDL cholesterol metabolism. However - after an early report in the late '90 s - no recent advance has been made about LCAT three-dimensional structure. In this paper, we propose an LCAT atomistic model, built following the most up-to-date molecular modeling approaches, and exploiting newly solved crystallog…

MaleModels MolecularProtein StructureDrug Research and DevelopmentProtein Conformationlcsh:MedicineBiologyBiochemistryCatalysisSubstrate SpecificityPhosphatidylcholine-Sterol O-AcyltransferaseMicechemistry.chemical_compoundEnzyme activatorTransacylationProtein structureDrug DiscoveryHydrolaseCatalytic triadBiochemical SimulationsMedicine and Health SciencesAnimalsHumansHomology modelingBiomacromolecule-Ligand Interactionslcsh:SciencePharmacologyBinding SitesPlasma ProteinsMultidisciplinarylcsh:RBiology and Life SciencesProteinsEnzyme structureEnzyme ActivationMolecular Docking SimulationchemistryBiochemistryMutationEnzyme StructureEnzymologyBiocatalysisCholesteryl esterlcsh:QResearch ArticleBiotechnologyPLoS ONE
researchProduct